The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein

Published:1996-09 Issue:1 Volume:14 Page:33-41
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Borrow Julian,Stanton Vincent P.,Andresen J. Michael,Becher Reinhard,Behm Frederick G.,Chaganti Raju S. K.,Civin Curt I.,Disteche Christine,Dubé Ian,Frischauf Anna Marie,Horsman Doug,Mitelman Felix,Volinia Stefano,Watmore Ann E.,Housman David E.

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0996-33.pdf

Reference59 articles.

1. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 372, 143–149 (1994).

2. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic working classification of the acute myeloid leukemias. Cancer Genet. Cytogenet. 30, 1–15 (1988).

3. Hanslip, J.I., Swansbury, G.J., Pinkerton, R. & Catovsky, D. The translocation t (8;16) (p11;p13) defines an AML subtype with distinct cytology and clinical features. Leuk. Lymphoma 6, 479–486 (1992).

4. Mitelman, F. & Heim, S. Quantitative acute leukemia cytogenetics. Genes Chromosom. Cancer 5, 57–66 (1992).

5. Stark, B. et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t (8:16) (p11:p13), in a patient with the variant t (8:19) (p11:q13)-case report and review of the literature. Leuk. Res. 19, 367–379 (1995).

Cited by 697 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hypothetical model: Chromatin remodelers couple with acetyltransferases to trigger the elongation of RNA polymerase II (pol II);Frontiers in Epigenetics and Epigenomics;2024-08-01

2. Angelicin improves osteoporosis in ovariectomized rats by reducing ROS production in osteoclasts through regulation of the KAT6A/Nrf2 signalling pathway;Chinese Medicine;2024-07-02

3. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27

4. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes;Proceedings of the National Academy of Sciences;2024-06-18

5. Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial;Nature Medicine;2024-06-01